A Phase II Randomized Controlled Trial: Definitive Concurrent Chemoradiotherapy with Docetaxel Plus Cisplatin versus 5-Fluorouracil plus Cisplatin in Patients with Oesophageal Squamous Cell Carcinoma

Purpose: To evaluate the efficacy and toxicity of definitive concurrent chemoradiotherapy (CCRT) with docetaxel plus cisplatin (DP regimen) versus 5-fluorouracil plus cisplatin (PF regimen) in patients with oesophageal squamous cell carcinoma (ESCC). Patients and Methods: In this phase II randomized...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cancer
Autors principals: Zhu, Yujia, Zhang, Wenwen, Li, Qiaoqiao, Li, Qiwen, Qiu, Bo, Liu, Hui, Liu, Mengzhong, Hu, Yonghong
Format: Artigo
Idioma:Inglês
Publicat: Ivyspring International Publisher 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5688918/
https://ncbi.nlm.nih.gov/pubmed/29151952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.20053
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars